These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2781156)

  • 1. [Effect of mexiletine on human atrial vulnerability].
    Omori I; Inoue D; Shirayama T; Azuma A; Sugihara H; Furukawa K; Asayama J; Katsume H; Nakagawa M
    Kokyu To Junkan; 1989 Jun; 37(6):663-7. PubMed ID: 2781156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological effect of verapamil on human atrium].
    Inoue M; Inoue D; Omori I; Shirayama T; Yamahara Y; Asayama J; Katsume H; Nakagawa M
    Kokyu To Junkan; 1991 Sep; 39(9):891-7. PubMed ID: 1749867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency dependent prolongation of inter-atrial conduction time by mexiletine in human atrium].
    Sakai R; Inoue D; Ishibashi K; Inoue M; Omori I; Yamahara Y; Asayama J; Nakagawa M
    Kokyu To Junkan; 1993 Oct; 41(10):987-91. PubMed ID: 8235124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sick sinus syndrome with and without atrial fibrillation: atrial refractoriness and conduction characteristics.
    De Sisti A; Leclercq JF; Fiorello P; Di Lorenzo M; Manot S; Halimi F; Attuel P
    Cardiologia; 1999 Apr; 44(4):361-7. PubMed ID: 10371788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormalities of electrocardiographic P wave morphology and the relationship to electrophysiological parameters of the atrium in patients with idiopathic paroxysmal atrial fibrillation].
    Liu Z; Hayano M; Hirata T; Quin Y; Tsukahara K; Ishimatsu T; Sakamoto R; Iliev I; Iwamoto K; Ueyama C; Yano K
    J Cardiol; 1998 Sep; 32(3):189-96. PubMed ID: 9783240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome].
    Róna G
    Z Gesamte Inn Med; 1986 Jun; 41(12):355-8. PubMed ID: 3765734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of mexiletine in the Wolff-Parkinson-White syndrome].
    Touboul P; Gressard A; Kirkorian G; Atallah G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1315-23. PubMed ID: 6797370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mexiletine: electrophysiologic effects].
    Rizzo A; Sisto F; Fiorilli R; Lisanti P
    G Ital Cardiol; 1983 Nov; 13(11):306-10. PubMed ID: 6667817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of electrophysiological properties of asymptomatic Wolff-Parkinson-White syndromes. Comparison with symptomatic Wolff-Parkinson-White syndromes].
    Lescure-Ducay M; Queyrau JM; Bahna A; Dechandol A; Goutner C; Charrançon M; Berthoumieu H; Donzeau JP
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):83-7. PubMed ID: 8494323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical electrophysiological evaluation of mexiletine].
    Molina L; Colín L; Micheletti T; Blank S; Camacho J
    Arch Inst Cardiol Mex; 1986; 56(3):219-23. PubMed ID: 2944491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
    Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
    Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial stimulation and intranodal migration of sinus pacemaker in man (author's transl)].
    Masini G; Zanetti L; Dianda R
    G Ital Cardiol; 1981; 11(9):1198-210. PubMed ID: 6173282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation.
    Shimizu A; Fukatani M; Tanigawa M; Mori M; Hashiba K
    Jpn Circ J; 1989 Sep; 53(9):1023-30. PubMed ID: 2600995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
    Antunes E; da Silva N; Catarino C; Serra J; Galrinho A; Ferreira R; Quininha J; Gracias R; Rato JA
    Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation.
    Lesh MD; Van Hare GF; Fitzpatrick AP; Griffin JC; Chu E
    J Electrocardiol; 1993; 26 Suppl():194-203. PubMed ID: 8189124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling.
    Sanders P; Morton JB; Kistler PM; Spence SJ; Davidson NC; Hussin A; Vohra JK; Sparks PB; Kalman JM
    Circulation; 2004 Mar; 109(12):1514-22. PubMed ID: 15007004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.